How aspirin protects you from cancer

Aspirin and other nonsteroidal anti-inflammatory drugs reduce the risk of cancer by inducing apoptotic cell death. How this occurs, however, is unknown. A critical pathway for apoptosis involves the release of cytochrome c from mitochondria. This interacts with Apaf-1 to activate caspase proteases that orchestrate cell death. Douglas R. Green from La Jolla Institute for Allergy & Immunology, San Diego, and colleagues, found that treatment of a human cancer cell line with aspirin induced casp

By | January 11, 2001

Aspirin and other nonsteroidal anti-inflammatory drugs reduce the risk of cancer by inducing apoptotic cell death. How this occurs, however, is unknown. A critical pathway for apoptosis involves the release of cytochrome c from mitochondria. This interacts with Apaf-1 to activate caspase proteases that orchestrate cell death. Douglas R. Green from La Jolla Institute for Allergy & Immunology, San Diego, and colleagues, found that treatment of a human cancer cell line with aspirin induced caspase activation and the apoptotic cell morphology. The effect was blocked by the caspase inhibitor zVAD-fmk (Neoplasia 2000, 2:505-513).

Further analysis of the apoptotic event showed that aspirin induces mitochondrial release of cytochrome c into the cytosol. The release of cytochrome c from mitochondria was inhibited by overexpression of the antiapoptotic protein Bcl-2, and cells that lack Apaf-1 were resistant to aspirin-induced apoptosis.

These data provide evidence that the release of cytochrome c is an important part of the apoptotic mechanism of aspirin and add another new action for this old, but very useful drug.

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Researchers Build a Cancer Immunotherapy Without Immune Cells
  3. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech